Abnormal Tc-99m MAA accumulation

A. Hiltz; S. Iles

doi:10.1097/00003072-198810000-00009

Abnormal Tc-99m MAA accumulation

A. Hiltz, S. Iles

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

3 Citas (Scopus)

Resumen

Image findings are described in two patients who received radiochemically impure Tc-99m MAA radiopharmaceutical preparations. The cases are completely separate and show clinically the presence of hydrolyzed-reduced technetium (TcO₂) in a radiopharmaceutical product.

Idioma original	English
Páginas (desde-hasta)	727-729
Número de páginas	3
Publicación	Clinical Nuclear Medicine
Volumen	13
N.º	10
DOI	https://doi.org/10.1097/00003072-198810000-00009
Estado	Published - 1988
Publicado de forma externa	Sí

ASJC Scopus Subject Areas

Radiology Nuclear Medicine and imaging

Acceder al documento

10.1097/00003072-198810000-00009

Otros archivos y enlaces

Citar esto

@article{8c75ebd4b02445b2bbf601665edb0d30,

title = "Abnormal Tc-99m MAA accumulation",

abstract = "Image findings are described in two patients who received radiochemically impure Tc-99m MAA radiopharmaceutical preparations. The cases are completely separate and show clinically the presence of hydrolyzed-reduced technetium (TcO2) in a radiopharmaceutical product.",

author = "A. Hiltz and S. Iles",

year = "1988",

doi = "10.1097/00003072-198810000-00009",

language = "English",

volume = "13",

pages = "727--729",

journal = "Clinical Nuclear Medicine",

issn = "0363-9762",

publisher = "Lippincott Williams and Wilkins",

number = "10",

}

TY - JOUR

T1 - Abnormal Tc-99m MAA accumulation

AU - Hiltz, A.

AU - Iles, S.

PY - 1988

Y1 - 1988

N2 - Image findings are described in two patients who received radiochemically impure Tc-99m MAA radiopharmaceutical preparations. The cases are completely separate and show clinically the presence of hydrolyzed-reduced technetium (TcO2) in a radiopharmaceutical product.

AB - Image findings are described in two patients who received radiochemically impure Tc-99m MAA radiopharmaceutical preparations. The cases are completely separate and show clinically the presence of hydrolyzed-reduced technetium (TcO2) in a radiopharmaceutical product.

UR - http://www.scopus.com/inward/record.url?scp=0023723062&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023723062&partnerID=8YFLogxK

U2 - 10.1097/00003072-198810000-00009

DO - 10.1097/00003072-198810000-00009

M3 - Article

C2 - 3180597

AN - SCOPUS:0023723062

SN - 0363-9762

VL - 13

SP - 727

EP - 729

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

IS - 10

ER -

Abnormal Tc-99m MAA accumulation

Resumen

ASJC Scopus Subject Areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto